Ownership signal CIK-linked ownership evidence from parsed SEC filings. 2 signals
Large-stake signal

Form

SCHEDULE 13D/A

Active or control-oriented beneficial ownership filing.

Ownership

1.6%

Beneficial ownership of this reported class.

Shares

196,198 shares

Shares beneficially owned as disclosed.

Event date

16 Jan 2025

Date tied to the ownership event or amendment.

Accepted by SEC

21 Jan 2025

EDGAR acceptance date.

How to read this large-stake filing
  • Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
  • Compare this filing with the holder history and issuer page before treating the percentage as a current position.
  • Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Subject security Names, identifiers, and filing context for this profile. 2 source fields
Symbol
RPHM
Shares outstanding
12,657,935 shares
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
SCHEDULE 13D/A
Accepted by SEC
21 Jan 2025, 18:38:09 UTC
Event date
16 Jan 2025
Source filing
View source filing

Key filing fact

RiverVest Venture Fund III, L.P. disclosed 1.6% ownership in OnKure Therapeutics, Inc. Common Stock, par value $0.0001 per share (RPHM) on 16 Jan 2025.

Key facts

  • RiverVest Venture Fund III, L.P. filed SCHEDULE 13D/A for OnKure Therapeutics, Inc. Common Stock, par value $0.0001 per share (RPHM).
  • Disclosed ownership: 1.6%.
  • Date of event: 16 Jan 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 21 Jan 2025, 18:38.

Research use

  • This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
  • Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

View source filing

Reporting persons

Disclosed reporting parties (12)

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares owned Sole voting power Shared voting power Signature Title CIK
RiverVest Venture Fund III, L.P. 0.2% 25,400 0 25,400 By: RiverVest Venture Partners III, L.P., its general partner By: RiverVest Venture Partners III, LLC, its general partner By: /s/ Jay Schmelter Jay Schmelter/Member 0001601559
RiverVest Venture Fund III (Ohio), L.P. 0.01% 1,349 0 1,349 By: RiverVest Venture Partners III (Ohio), LLC, its general partner, as indicated in the signature block that immediately follows By:/s/ Jay Schmelter Jay Schmelter/Member 0001636686
RiverVest Venture Partners III (Ohio), LLC 0.01% 1,349 0 1,349 By: RiverVest Venture Partners III, L.P., its sole member By: RiverVest Venture Partners III, LLC, its general partner By: /s/ Jay Schmelter Jay Schmelter/Member 0001611644
RiverVest Venture Partners III, L.P. 0.21% 26,749 0 26,749 By: RiverVest Venture Partners III, LLC, its general partner By: /s/ Jay Schmelter Jay Schmelter/Member 0001752268
RiverVest Venture Partners III, LLC 0.21% 26,749 0 26,749 By: /s/ Jay Schmelter Jay Schmelter/Member 0001752405
RiverVest Venture Fund IV, L.P. 1.3% 169,449 0 169,449 By: RiverVest Venture Partners IV, L.P., its general partner By: RiverVest Venture Partners IV, LLC, its general partner By: /s/ Jay Schmelter Jay Schmelter/Member 0001725443
RiverVest Venture Partners IV, L.P. 1.3% 169,449 0 169,449 By: RiverVest Venture Partners IV, LLC, its general partner By: /s/ Jay Schmelter Jay Schmelter/Member
RiverVest Venture Partners IV, LLC 1.3% 169,449 0 169,449 By: /s/ Jay Schmelter Jay Schmelter/Member
John P. McKearn, Ph.D. 1.6% 196,198 0 196,198 /s/ John P. McKearn, Ph.D. John P. McKearn, Ph.D. 0001240120
Jay Schmelter 1.6% 196,198 0 196,198 /s/ Jay Schmelter Jay Schmelter 0001435248
Thomas C. Melzer 0.21% 26,749 0 26,749 /s/ Thomas C. Melzer Thomas C. Melzer 0001611651
Niall O'Donnell, Ph.D. 1.3% 169,449 16,595 169,449 /s/ Niall O'Donnell, Ph.D. Niall O'Donnell, Ph.D. 0001780235
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .